Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 15.5% in the year so far compared with the industry’s decline of ...

Shares of Regeneron Pharmaceuticals Inc. REGN slipped 4.14% to $740.97 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.54 ...

Biotech companies are making monumental strides in cancer treatment, leveraging cutting-edge technologies to redefine the ...

Representative Josh Gottheimer also recently made the following trade(s): Shares of REGN stock opened at $778.00 on Friday. The business has a 50-day moving average price of $882.14 and a two-hundred ...

REGN dropped to an RSI of about 10 ... the outcome of the DOJ case and the amount of the potential fine. The stock price may also have limited upside until a decision is made in the courts.

If an investor was to purchase shares of REGN stock at the current price level of $756.89/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

NEW YORK, NY / ACCESSWIRE / December 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Regeneron ...

Shares of Regeneron Pharmaceuticals Inc. REGN slumped 0.62% to $750.22 Friday, on what proved to be an all-around positive ...